Although the MPO level is upregulated in obese individuals irrespective of the diabetes status, the ANGPTL6 level is elevated in diabetic patients regardless of their BMI, which reflects the unique physiological function of each of these markers and emphasizes the need for comprehensive studies to better understand these functions and utilize them for diagnosis and therapeutic purposes. The gene discussed is MPO; the disease is diabetes mellitus.